Katharine E. Spink, Chief Operating Officer at Asterias Biotherapeutics, Inc. (AST), sold 12,440 shares at $4.11 ($39K) on 2016-10-06, disclosed to the SEC on 2016-10-11.
Open-market sale of $39k AST by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,878 | $0 | 0.0% |
| 2 | $4.11 | 4,781 | $20K | 50.0% |
| 3 | $4.11 | 4,781 | $20K | 50.0% |
| Total | $3.16 avg | 12,440 | $39K | 100% |
| Filing → |
| AST | SELL | 2016-11-28 | $14K | — | Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-09-12 | $68K | — | Filing → |